5-甲基胞嘧啶锁核酸的合成新方法

设计了一种新的合成5-甲基胞嘧啶锁核酸{(1R,3R,4R,7S)-3-[(5-甲基-4-N-苯甲酰基胞嘧啶-1-基)-7-(2-氰基乙氧基)-(N,N-二异丙基)膦氧代]-1-(4,4’-二甲氧基三苯代甲基氧基甲基)-2,5-二氧杂二环-[2.2.1]庚烷(1)}的方法。以3-苄氧基-4-C-羟甲基-1,2-O-异亚丙基-α-D-呋喃核糖为起始原料,经取代、水解等12步反应合成了1,总收率21.0%,其结构经1H NMR和MS确证。     

一种胞苷衍生物的合成

以胞苷为原料,首先通过单乙酰化反应保护-NH2;再分别用二对甲氧基三苯甲基氯和氯甲氧基三异丙基硅烷保护5-′OH和2-′OH;被保护的胞苷经磷酰化反应合成了一种用于制备RNA长链的胞苷衍生物单体——N-乙酰基-5′-O-二对甲氧基三苯甲基-2′-O-三异丙基硅氧甲基-3′-O-双(N,N-二异丙基氨基)(2-氰乙氧基)磷基胞苷(1),总收率29.8%。1及其中间体的结构经1H NMR,MS和元素分析表征。     

利托那韦的合成新方法

建立了利托那韦的合成新方法。N-{N-甲基-N-[(2-异丙基-4-噻唑基)甲基]氨基羰基}-L-缬氨酸(1)与(2S,3S,5S)-5-氨基-2-{N-[(5-噻唑基)-甲氧羰基]氨基}-1,6-二苯基-3-羟基己烷在3-(二乙氧基磷酰氧基)-1,2,3-苯并三嗪-4-酮催化下于室温经缩合反应合成了利托那韦,其结构经1H NMR,13C NMR,MS和元素分析确证。在最佳反应条件[1 0.2 mol,DEPBT 0.25 mmol,二氯甲烷为溶剂,三乙胺为缚酸剂,于室温反应过夜]下,收率72.6%。     

含有三苯胺环类席夫碱的合成

以4,4’-二甲酰基三苯胺为原料,通过Wittig和胺醛缩合反应合成了两个含有三苯胺环席夫碱类化合物——4-(对甲基苯乙烯基)-4’-亚(α-萘胺)甲基三苯胺和4-(对甲基苯乙烯基)-4’-亚(2-氨基芴)甲基三苯胺,其结构经1H NMR,13CNMR和IR确证。     

O-(1,3-二芳硒基)异丙基-O-2-(N3-替加氟)乙基硫代磷酯的合成及其抗癌活性

六乙基亚磷酰三胺依次与羟乙基替加氟、1-芳硒基甘油及硫反应,得到环甘油硫代磷脂替加氟缀合物(2a～2e);通过苯硒化钾对2进行亲核开环,得到O-(1,3-二芳硒基)异丙基-O-2-(N-替加氟)乙基硫代磷酯(3a～3e),其结构经1H NMR,31P NMR,MS及元素分析确证.3对膀胱癌细胞PGA1有一定的抑制作用.     

1,1-二苯基(或4,4'-二溴二苯基)-3-(3-三乙氧基硅基)丙基脲的合成

以三乙胺为缚酸剂,二苯胺和4,4'-二溴二苯胺分别与三光气反应制得N,N-二苯基氨基甲酰氯(2a)和N,N-(4,4'-二溴二苯基)氨基甲酰氯(2b);2a和2b分别与3-氨丙基三乙氧基硅烷反应合成了两个新型的含非对称取代脲的功能性有机硅氧烷——1,1-二苯基-3-(3-三乙氧基硅基)丙基脲和1,1-(4,4'-二溴二苯基)-3-(3-三乙氧基硅基)丙基脲,其结构经1H NMR,13C NMR和IR表征。     

C5a受体拮抗剂W-54011的合成

以7-甲氧基-1-萘满酮为原料,经Wittig反应、去甲基化、烯醇互变和Jones氧化反应等制得关键中间体7-甲氧基-1,2,3,4-四氢化萘-1-羧酸(4); 4-异丙基苯胺和4-(二甲基胺基)苯甲醛经过还原胺化反应得(E)-4-{[(4-异丙基苯基)亚胺基]甲基}-N,N-二甲基苯胺(6); 4转化为相应的酰氯后与6反应合成N-[4-(二甲基氨基)苄基]-N-(4-异丙基苯基)-7-甲氧基-1,2,3,4-四氢化萘-1-甲酰胺(W-54011),总收率24%,其结构经¹H NMR, ¹³C NMR和HR-MS（ESI）表征。      

尼达尼布的合成

间硝基苯甲酸甲酯(1)与氯乙酸甲酯反应制得4-甲氧基羰基甲基-3-硝基苯甲酸甲酯(2);2依次经催化氢化、乙酰化及与原苯甲酸三乙酯反应制得关键中间体(E)-1-乙酰基-3-(乙氧基-苯基-甲烯基)-2-氧-2,3-二氢-1H-吲哚-6-羧甲酸甲酯(5);N-甲基对硝基苯胺依次经氯乙酰化、取代和催化氢化反应制得N-(4-氨基苯基)-N-甲基-2-(4-甲基哌嗪-1-基)乙酰胺(9);5和9经拼合合成了治疗特发性肺纤维化药尼达尼布,总收率22.0%,纯度99.4%,其结构经1H NMR和MS确证。     

N-[4-(三氟甲氧基)苯基]氨基甲酸苯酯的合成

以三氟甲氧基苯为起始原料，经硝化、加氢还原和酰化反应合成了N-[4-(三氟甲氧基)苯基\]氨基甲酸苯酯，总收率84.6%，纯度98.9%，其结构经¹H NMR和MS（ESI）确证。     

脂质体药用辅料mPEG2000-DSPE的合成

以氧氯化磷、乙醇胺及1,2-二硬脂酸甘油酯为原料,经环合、磷酰化及水解反应制得1,2-二硬脂酰甘油磷酰乙醇胺（DSPE）;在N,N′-羰基二咪唑作用下,DSPE与甲氧基聚乙二醇（mPEG2000）反应合成了1,2-二硬脂酰甘油磷脂酰乙醇胺N-甲氧基聚乙二醇2000（mPEG2000-DSPE）,其结构经¹H NMR, IR和MS（ESI）确证。     

新型砜基聚苯并咪唑的合成

采用新的合成路线,以多聚磷酸催化4,4′-二羧基二苯砜与邻苯二胺反应制得双苯并咪唑二苯砜(3);以3和4,4′-二氟二苯砜为单体,环丁砜为溶剂,在无水碳酸钾存在下合成了新型砜基聚苯并咪唑,其结构经1H NMR,IR,MS和元素分析表征.     

Synthesis of N-Hetarylthiourea Derivatives of Carbohydrates

ABSTRACT

The syntheses of N-hetaryl (thiazole-2-yl, 2-thiazoline-2-yl, 4,4-diphenyloxazoline-2-yl, cis-3a,4,5,6,7,7a-hexahydrobenzoxazole-2-yl)-N′-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl) thioureas (1a-1d), N-hetaryl (2-thiazoline-2-yl, 4,4-diphenyloxazoline-2-yl)-N′-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl) thioureas (2b, 2c) and 1,2,3,4,6-tetra-O-acetyl-2-deoxy-2-[3-(4′, 4′-diphenyl-2′-y1) thioureido]-β-D-glucopyranose (3c) are described. The structures and conformational properties of prepared compounds are based on analytical and spectroscopic (UV, IR, NMR and MS) data.     

氯沙坦的合成工艺改进

以2-氰基-4′-溴甲基联苯和2-丁基-4-氯-5-甲酰基 咪唑为原料,依次经N-烷基化、羟基化和四唑化反应合成了氯沙坦,总收率73.9%,其结构经¹H NMR和MS（ESI）确证。     

A Novel Method for Synthesizing 4,4′-Bis(hydroxymethyl)-2,2′-bipyridine

IntroductionSince C. W. Tang firstly reported theelectroluminescence of 8- hydroxyquinolinealuminium[1] ,much attention has been paid to themetal complexes as electro- luminescent materials.Based on a series of experimental data,it has beenknown that the electroluminescence of metalcomplexes with heterocyclic ligands containing Nand O elements mainly results from the tripletstatetransition.For some transitional metal complexes,there exist the transitions from metal to ligand( MLCT) at thei…     

伐地那非的合成工艺改进

以2-乙氧基苯腈为原料,依次经Pinner反应和肼解反应制得中间体2-乙氧基苯甲亚胺酸酰肼（3）; 3经两步环合,氯磺化和氨化反应制得伐地那非,其结构经¹H NMR, ¹³C NMR和MS（ESI）确证,总收率31.6%。     

天然产物Angustifolin D中间体的合成

以3,4,5-三甲氧基苯甲酸为原料,经6步反应以23％总收率完成了Angustifolin D关键中间体--6,6′-2［(Z)-2-碘代-1-丙烯基］-2,2′,3,3′,4,4′-六甲氧基-1,1′-联苯(7)的合成,其结构经¹H NMR, ¹³C NMR, IR和MS确证。其中关键步骤联苯偶连反应采用了廉价易得的铜试剂(CuBr·SMe₂)作为催化剂。     

New Lignans from the Aerial Parts of Rudbeckia laciniata

Three new furofuran lignans, (+)‐4,4′‐O‐diangeloylpinoresinol ( 1 ), (+)‐4,4′‐O‐diangeloylmedioresinol ( 2 ), and (+)‐4,4′‐O‐diangeloylsyringaresinol ( 3 ), together with the known compound (+)‐syringaresinol, were isolated from the MeOH extract of Rudbeckia laciniata. The structure elucidation of these compounds were based on 1D‐ and 2D‐NMR, and HR‐ESI‐MS data. The additional structural evidence was obtained from alkaline hydrolysis of the compounds.     

Synthesis, Dimeric Crystal Structure, and Biological Activities of N-(4-Methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl)-N-(2-trifluoromethyl-phenyl)-guanidine

The title compound, N-(4-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl)-N′-(2-trifluoromethyl-phenyl)-guanidine, was synthesized and its structure was confirmed by using IR, MS, 1H NMR, and elemental analysis. The single crystal structure of the title compound was determined by X-ray diffraction. The preliminary biological test showed that the synthesized compound has a weak herbicidal activity.     

Synthesis of Two Metabolites of the Antiarrythmicum Amiodarone

The metabolism of the potent antiarrythmic drug amiodarone (AMI; 1 ) has yet not been fully investigated. Recently, in vitro experiments revealed that in rabbit‐liver microsomes, AMI ( 1 ) and its main metabolite MDEA ( 2 ) were biotransformed to the hydroxylated derivatives 3′‐OH‐AMI ( 3 ) and 3′‐OH‐MDEA ( 4 ), respectively. To establish the chemical structure of 3 and 4 , we developed a total synthesis of these two metabolites of AMI ( 1 ). ¹H‐ and ¹³C‐NMR Signal assignment from HSQC and HMBC 2D NMR data of synthesized 4 showed that the proposed structure of metabolite 4 is correct. Even the structure of 3 was found to be correct by comparing its HPLC/MS‐MS/MS with the data described earlier.     

A Practical Synthesis of 3′-Thioguanosine and of Its 3′-Phosphoramidothioite (a Thiophosphoramidite)

Starting from guanosine, an efficient method for the synthesis of 3′-thioguanosine (see 13 ) and of its 3′-phosphoramidothioite (see 23 ), suitable for automated incorporation into oligonucleotides, was developed. Reaction of 5′-N²-protected guanosine with 2-acetoxyisobutyryl bromide afforded stereoselectively the 2′-O-acetyl-3′-bromo-β-D -xylofuranosyl derivative 3 , which was converted to a 7 : 3 mixture of the S-acyl ribofuranosyl intermediates 5 or 6 and the 3′,4′-unsaturated by-product 4 . The S-acylated nucleosides 5 and 6 were then converted in three steps to 5′-O-(4,4′-dimethoxytrityl)-3′-S-(pyridin-2-ylthio)-3′-thioguanosine ( 11 ), which served as a common intermediate for the preparation of free 3′-thionucleoside 13 and 3′-thionucleoside 3′-phosphoramidothioite 23 .